These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33393853)

  • 1. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'.
    Dhama K; Singh Malik Y; Rabaan AA; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2020 Dec; 16(12):2888-2890. PubMed ID: 33393853
    [No Abstract]   [Full Text] [Related]  

  • 2. Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    Figueroa JP; Hotez PJ; Batista C; Ben Amor Y; Ergonul O; Gilbert S; Gursel M; Hassanain M; Kang G; Kaslow DC; Kim JH; Lall B; Larson H; Naniche D; Sheahan T; Shoham S; Wilder-Smith A; Sow SO; Strub-Wourgaft N; Yadav P; Bottazzi ME
    PLoS Med; 2021 Sep; 18(9):e1003772. PubMed ID: 34516558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in vaccine and immunotherapy for COVID-19.
    Rabaan AA; Al-Ahmed SH; Sah R; Al-Tawfiq JA; Al-Qaaneh AM; Al-Jamea LH; Woodman A; Al-Qahtani M; Haque S; Harapan H; Bonilla-Aldana DK; Kumar P; Dhama K; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2020 Dec; 16(12):3011-3022. PubMed ID: 33156739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine against SARS-CoV-2 in previously infected health care workers.
    Parisi SG
    EBioMedicine; 2021 Sep; 71():103556. PubMed ID: 34454402
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
    Karthik K; Senthilkumar TMA; Udhayavel S; Raj GD
    Hum Vaccin Immunother; 2020 Dec; 16(12):3055-3060. PubMed ID: 32845733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How nano can fight the virus.
    Ball P
    Nat Mater; 2021 Feb; 20(2):126. PubMed ID: 33504984
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 infection confers greater immunity than shots.
    Wadman M
    Science; 2021 Sep; 373(6559):1067-1068. PubMed ID: 34516858
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Connors M; Graham BS; Lane HC; Fauci AS
    Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarrier vaccines for SARS-CoV-2.
    Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD
    Adv Drug Deliv Rev; 2021 Apr; 171():215-239. PubMed ID: 33428995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovators target vaccines for variants and shortages in global South.
    Sheridan C
    Nat Biotechnol; 2021 Apr; 39(4):393-396. PubMed ID: 33731936
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 vaccines for patients with haematological conditions.
    Sun C; Pleyer C; Wiestner A
    Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
    de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
    Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.
    Iqbal Yatoo M; Hamid Z; Parray OR; Wani AH; Ul Haq A; Saxena A; Patel SK; Pathak M; Tiwari R; Malik YS; Sah R; Rabaan AA; Rodriguez Morales AJ; Dhama K
    Hum Vaccin Immunother; 2020 Dec; 16(12):2891-2904. PubMed ID: 32703064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 18. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
    Martin P; Clarke C
    EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.